EUGENE R AHN
Medical Practice at Ave, Miami, FL

License number
Florida 92099
Issued Date
Dec 13, 2004
Effective Date
Feb 1, 2017
Expiration Date
Jan 31, 2015
Category
Health Care
Type
Medical Doctor
Address
Address
800 W West Ave WEST APT 721, Miami, FL 33139

Organization information

See more information about EUGENE R AHN at bizstanding.com

Eugene R Ahn

1100 W Ave, Miami, FL 33139

Status:
Inactive
Industry:
Business Services at Non-Commercial Site
Principal:
Eugene Ahn Principal, inactive

Professional information

Eugene Ahn Photo 1

Dr. Eugene Ahn - MD (Doctor of Medicine)

Hospitals:
UM/Sylvester Comprehensive Cancer Center
1475 D8-4 STE 3300, Miami 33136
Sylvester Comprehensive Cancer Center/UMHC
1475 West 12Th Ave, Miami 33136
UM/Sylvester Comprehensive Cancer Center
1475 D8-4 STE 3300, Miami 33136
Sylvester Comprehensive Cancer Center/UMHC
1475 West 12Th Ave, Miami 33136
Education:
Medical Schools
U Of Miami L M Miller Som
Graduated: 1997


Eugene Rim Ahn Photo 2

Eugene Rim Ahn, Miami FL

Specialties:
Oncologist
Address:
1475 Nw 12Th Ave, Miami, FL 33136
Education:
Doctor of Medicine
Board certifications:
American Board of Internal Medicine Sub-certificate in Infectious Disease (Internal Medicine), American Board of Internal Medicine Sub-certificate in Oncology (Internal Medicine)


Eugene Ahn Photo 3

Eugene Ahn, Miami FL

Work:
Miami Va Healthcare System
1201 NW 16Th St, Miami, FL 33125


Eugene Ahn Photo 4

Cell-Derived Microparticles As Hemostatic Agents For Control Of Hemorrhage And Treatment Of Bleeding Disorders

US Patent:
2008006, Mar 20, 2008
Filed:
Dec 7, 2005
Appl. No.:
11/792399
Inventors:
Wenche Jy - Miami FL, US
Joaquin Jimenez - Miami FL, US
Lawrence Horstmann - Miami FL, US
Yeon Ahn - Miami FL, US
Eugene Ahn - Miami FL, US
Assignee:
University of Miami - Miami FL
International Classification:
A61K 35/16, A61P 7/00
US Classification:
424093720
Abstract:
Compositions comprising membrane-derived and synthetic microparticles that induce platelet aggregation and are useful for treating bleeding disorders, particularly those involving platelet dysfunction. Microparticles include endothelial derived microparticles (EMP), platelet derived microparticles (PMP), erythrocyte derived microparticles (RMP), and synthetic microparticles (SMP), and are used to treat disorders such as thrombocytopenia caused by chemotherapy.